Visual Quality Change of Eyes Implanted With Diffractive Multifocal Intraocular Lens After Cataract Surgery
Launched by WENZHOU MEDICAL UNIVERSITY · Sep 8, 2014
Trial Information
Current as of May 16, 2025
Unknown status
Keywords
ClinConnect Summary
50 eyes of 50 cataract patients scheduled for phacoemulsification surgery were recruited, the multifocal group (25 eyes) ，were implantation with Tecnis® ZMB00；and the monofocal group (25 eyes) were implantation with Tecnis® ZCB00.
Methods: All eyes were examined by logMAR visual acuity chart and Optical quality analysis system (OQAS) at 1 week, 1 month, 3 month, 6 month,12 month after surgery for the subjective and objective visual quality Change during the first year.
Measures:Subjective and objective visual quality were evaluated.Tear-film quality dynamicswere evaluated.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Eyes with an axial length of 22.00 to 25.00 mm with age-related cataract.
- Exclusion Criteria:
- • Preoperative exclusion criteria included diabetes, history of ocular surgery or inflammation.
- • Patients who could not be available for follow-up.
About Wenzhou Medical University
Wenzhou Medical University is a prestigious academic institution in China, dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on medical education, the university fosters collaboration between researchers and healthcare professionals to address pressing medical challenges. Its commitment to excellence in clinical research is reflected in its rigorous methodologies and adherence to ethical standards, ensuring the safety and well-being of trial participants. By leveraging cutting-edge technology and a diverse pool of expertise, Wenzhou Medical University aims to contribute significantly to the global medical community and improve patient outcomes through evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wenzhou, Zhejiang, China
Patients applied
Trial Officials
Fang Yu
Study Director
Affiliated Eye Hospital of Wenzhou Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials